Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amimestrocel in Acute Kidney Injury
NCT06954740Phase 2Recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Jun 2025
- Primary completion
- Aug 2026
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of amimestrocel in acute kidney injury (AKI), sponsored by Chinese PLA General Hospital. Started Jun 2025; status: recruiting.
02
Drugs
amimestrocel
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT06954740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06954740.